American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -463 | -138 | -801 | -556 | -796 |
| Depreciation Amortization | 68 | 53 | 36 | 18 | 96 |
| Accounts receivable | 103 | -121 | 37 | 87 | -40 |
| Accounts payable and accrued liabilities | 105 | 90 | 16 | 52 | -75 |
| Other Working Capital | -181 | -59 | 4 | 55 | -17 |
| Other Operating Activity | -305 | -658 | 92 | -15 | 349 |
| Operating Cash Flow | $-673 | $-833 | $-616 | $-359 | $-483 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -4 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,119 | 1,712 | 1,143 | 595 | 3,949 |
| Debt Issued | 714 | 632 | 564 | 381 | 532 |
| Debt Repayment | -25 | -25 | -25 | -25 | -42 |
| Other Financing Activity | -2,118 | -1,543 | -1,134 | -628 | -3,858 |
| Financing Cash Flow | $690 | $776 | $548 | $323 | $581 |
| Beginning Cash Position | 98 | 98 | 98 | 98 | 4 |
| End Cash Position | 115 | 41 | 30 | 63 | 98 |
| Net Cash Flow | $17 | $-57 | $-68 | $-35 | $94 |
| Free Cash Flow | |||||
| Operating Cash Flow | -673 | -833 | -616 | -359 | -483 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -4 |
| Free Cash Flow | -673 | -833 | -616 | -359 | -487 |